Serum elements and oxidative status in clinically isolated syndromes: Imbalance and predictivity

Neurology

Volumn 76, Issue 6, 2011, Pages 549-555

  Ristori, G ^a   Brescianini, S ^c   Pino, A ^d   Visconti, A ^a   Vittori, D ^a   Coarelli, G ^a   Cotichini, R ^c   Bocca, B ^d   Forte, G ^d   Pozzilli, C ^b   Pestalozza, I ^b   Stazi, M A ^c   Alimonti, A ^d   Salvetti, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Centre for Epidemiology Surveillance and Health Promotion   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; ANTIMONY; ANTIOXIDANT; CADMIUM; CALCIUM; CHROMIUM; COBALT; COPPER; IRON; LEAD; LITHIUM; MAGNESIUM; MANGANESE; MERCURY; MOLYBDENUM; NICKEL; STRONTIUM; THALLIUM; TIN; TUNGSTEN; VANADIUM; ZINC; ZIRCONIUM;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICALLY DEFINITE MULTIPLE SCLEROSIS; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PREDICTION; PRIORITY JOURNAL;

EID: 79951652370     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31820af7de     Document Type: Article

References (40)

1. Miller D, Barkhof F, Montalban X, Thompson A, Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005;4:281-288. (Pubitemid 40545039)
2. Swanton JK, Rovira A, Tintore M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 2007;6:667-686.
3. Brex PA, Ciccarelli O, O'Riordan JI, Sailer M, Thompson AJ, Miller DH. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002;346:158-164. (Pubitemid 34438881)
4. Rocca MA, Agosta F, Sormani MP, et al. A three-year, multi-parametric MRI study in patients at presentation with CIS. J Neurol 2008;255:683-691.
5. Moraal B, Pohl C, Uitdehaag BM, et al. Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study. Arch Neurol 2009;66:1345-1352.
6. Tintoré M, Rovira A, Brieva L, et al. Isolated demyelinat-ing syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS. Mult Scler 2001;7:359-363. (Pubitemid 33138345)
7. Berger T, Rubner P, Schautzer F, et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 2003;349:139-145. (Pubitemid 36818783)
8. Kuhle J, Pohl C, Mehling M, Edan G, et al. Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med 2007;356:371-378. (Pubitemid 46148779)
9. Bates MN, Fawcett J, Garrett N, Cutress T, Kjellstrom T. Health effects of dental amalgam exposure: a retrospective cohort study. Int J Epidemiol 2004;33:894-902. (Pubitemid 39263875)
10. Johnson S. The possible role of gradual accumulation of copper, cadmium, lead and iron and gradual depletion of zinc, magnesium, selenium, vitamins B2, B6, D, and E and essential fatty acids in multiple sclerosis. Med Hypoth 2000;55:239-241.
11. Park RM, Boal WL, Krebs JM. Multiple sclerosis (MS) in an Illinois community. Arch Environ Health 2002;57:383.
12. Gonsette RE. Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity. J Neurol Sci 2008;274:48-53.
13. Alimonti A, Ristori G, Giubilei F, et al. Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis. Neurotoxicology 2007;28:450-456. (Pubitemid 46843231)
14. Pestalozza I, Pozzilli C, Di Legge S, et al. Monthly brain magnetic resonance imaging scans in patients with clinically isolated syndrome. Mult Scler 2005;11:390-394. (Pubitemid 40984231)
15. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-1452. (Pubitemid 14237132)
16. Abo-Krysha N, Rashed L. The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study. Mult Scler 2008;14:602-608. (Pubitemid 351954401)
17. Van Rensburg SJ, van Zyl J, Hon D, et al. Biochemical model for inflammation of the brain: the effect of iron and transferring on monocytes and lipid peroxidation. Metab Brain Dis 2004;19:97-112. (Pubitemid 39005629)
18. Bakshi R, Shaikh ZA, Janardhan V. MRI T2 shortening (black T2) in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport 2000;11:15-21. (Pubitemid 30053382)
19. Hammond KE, Metcalf M, Carvajal L, et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol 2008;64:707-713.
20. Walter U, Wagner S, Horowski S, Benecke R, Zettl UK. Transcranial brain sonography findings predict disease progression in multiple sclerosis. Neurology 2009;73:1010-1017.
21. Ceccarelli A, Rocca MA, Neema M, et al. Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis. Mult Scler 2010;16:39-44.
22. Bettencourt A, Silva AM, Santos E, et al. HFE gene polymorphisms and severity in Portuguese patients with multiple sclerosis. Eur J Neurol Epub 2010.
23. Ramagopalan SV, Cukjati M, Cernilec M, et al. Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis. J Neuroimmunol 2008;203:104-107.
24. Adams CW. Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry 1988;51:260-265. (Pubitemid 18055135)
25. Zeis T, Probst A, Steck AJ, et al. Molecular changes in white matter adjacent to an active demyelinating lesion in early multiple sclerosis. Brain Pathol 2009;19:459-466.
26. Martino G, Clementi E, Brambilla E, et al. Gamma interferon activates a previously undescribed Ca2+ influx in T lymphocytes from patients with multiple sclerosis. Proc Natl Acad Sci USA 1994;91:4825-4829.
27. Kornek B, Storch MK, Bauer J, et al. Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 2001;124:1114-1124. (Pubitemid 32510379)
28. Stirling DP, Stys PK. Mechanisms of axonal injury: inter-nodal nanocomplexes and calcium deregulation. Trends in Molecular Medicine 2010;16:160-170.
29. Hartung HP, Kieseier BC. The role of matrix metalloprotein-ases in autoimmune damage to the central and peripheral nervous system. J Neuroimmunol 2000;107:140-147. (Pubitemid 30347419)
30. Espejo C, Martínez-Caceres EM. The role of methallothion-eins in experimental autoimmune encephalomyelitis and multiple sclerosis. Ann NY Acad Sci 2005;1051:88-96. (Pubitemid 41362735)
31. van Toorn R, Schoeman JF, Solomons R, Rensburg MA, van Rensburg SJ. Iron status in children with recurrent episodes of tumefactive cerebral demyelination. J Child Neurol Epub 2010.
32. Jafari N, Kreft KL, Flach HZ, et al. Callosal lesion predicts future attacks after clinically isolated syndrome. Neurology 2009;73:1837-1841.
33. Corvol JC, Pelletier D, Henry RG, et al. Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event. Proc Natl Acad Sci USA 2008;105:11839-11844.
34. Masjuan J, Alvarez-Cermeno JC, García-Barragan N, et al. Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS. Neurology 2006;66: 576-578. (Pubitemid 43739891)
35. Cameron EM, Spencer S, Lazarini J, et al. Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis. J Neuroimmunol 2009;213:123-130.
36. Brettschneider J, Tumani H, Kiechle U, et al. IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome. PLoS One 2009;4:7638.
37. Comabella M, Fernandez M, Martin R, et al. Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis. Brain 2010;133:1082-1093.
38. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis: part I: the role of infection. Ann Neurol 2007;61:288-299. (Pubitemid 46676728)
39. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria." Ann Neurol 2005;58:840-846. (Pubitemid 41746873)
40. Lünemann JD, Tintore M, Messmer B, et al. Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol 2010;67:159-169.